Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

NCT ID: NCT05712200

The LILAC-TIMI 76 clinical trial is investigating the safety and effectiveness of a drug called abelacimab for patients with Atrial Fibrillation (AF) who are at high risk for blood clots but cannot...

Recruiting

Phase: PHASE3 Conditions: Atrial Fibrillation (AF)

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT ID: NCT06465186

This clinical trial is studying a new medicine called efinopegdutide to see if it can help people with a liver disease known as metabolic dysfunction-associated steatohepatitis (MASH), which is cau...

Recruiting

Phase: PHASE2 Conditions: NAFLD, Non-alcoholic Fatty Liver Disease +3 more

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

Recruiting

Conditions: Lumbar Spinal Stenosis

RA-PRO PRAGMATIC TRIAL

NCT ID: NCT04692493

The RA-PRO Pragmatic Trial is a study designed to help doctors understand the best treatment options for people with rheumatoid arthritis (RA) who are not responding well to their current treatment...

Recruiting

Phase: PHASE3 Conditions: Rheumatoid Arthritis

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06290934

This clinical trial is studying a new treatment called GS-1427 for people with moderately to severely active ulcerative colitis, a condition that causes inflammation in the digestive tract. The mai...

Recruiting

Phase: PHASE2 Conditions: Ulcerative Colitis

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

NCT ID: NCT04513717

The PREDICT-RT Trial is a clinical study aimed at finding the best treatment options for men with high-risk prostate cancer. The trial is testing two different approaches: for patients with a low g...

Recruiting

Phase: PHASE3 Conditions: Prostate Adenocarcinoma, Stage IVA Prostate Cancer AJCC v8 +1 more

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

NCT ID: NCT05050084

This clinical trial is designed to explore different treatment approaches for men with unfavorable intermediate risk prostate cancer. The trial uses a special test called the Decipher risk score to...

Recruiting

Phase: PHASE3 Conditions: Prostate Adenocarcinoma

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT ID: NCT06532279

This clinical trial is studying whether adding a drug called BMX-001 to the usual treatment for head and neck cancer can help reduce a painful side effect called oral mucositis, which causes mouth ...

Recruiting

Phase: PHASE2 Conditions: Head and Neck Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma +39 more

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

NCT ID: NCT06847854

This clinical trial is studying a new treatment called RO7497372 for people with Diabetic Macular Edema (DME), a condition that can cause vision problems due to diabetes. The trial will look at how...

Recruiting

Phase: PHASE1 Conditions: Diabetic Macular Edema

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT ID: NCT06632444

The LIVERAGE™ clinical trial is studying a medication called survodutide to see if it can help adults with a liver disease known as Metabolic Dysfunction Associated Steatohepatitis (MASH) who also ...

Recruiting

Phase: PHASE3 Conditions: Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

NCT ID: NCT06632457

The LIVERAGE™ study is researching whether a medication called survodutide can help adults with a liver disease known as non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction Associated Steatohepatitis

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

NCT ID: NCT07009860

The RESTORE TRIAL is a clinical study designed to evaluate a new treatment called pemvidutide for people with Alcohol-Associated Liver Disease (ALD). This is a Phase 2 trial, meaning it's looking a...

Recruiting

Phase: PHASE2 Conditions: Alcohol Liver Disease

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT ID: NCT05797610

This clinical trial is studying a new treatment called RO7434656 for patients with Primary IgA Nephropathy (IgAN), a kidney disease that can lead to serious complications. The main goal is to see i...

Recruiting

Phase: PHASE3 Conditions: Primary IgA Nephropathy

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)

NCT ID: NCT06846515

This clinical trial, called AR882-301, is studying a new treatment called AR882 for patients with gout, a type of arthritis that causes painful swelling in the joints. The main goal is to see if AR...

Recruiting

Phase: PHASE3 Conditions: Gout, Hyperuricemia +2 more

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

NCT ID: NCT06690398

This clinical trial is studying a medication called Lumateperone to see if it can help reduce irritability in children and teenagers aged 5 to 17 who have Autism Spectrum Disorder (ASD). The study ...

Recruiting

Phase: PHASE3 Conditions: Irritability Associated With Autism Spectrum Disorder

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

NCT ID: NCT06331312

This clinical trial is looking at the long-term safety and tolerability of a medication called secukinumab for patients with polymyalgia rheumatica (PMR), a condition that causes muscle pain and st...

Recruiting

Phase: PHASE3 Conditions: Polymyalgia Rheumatica

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT ID: NCT06528314

This clinical trial is studying a new medication called efruxifermin (EFX) for people with compensated cirrhosis caused by nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated st...

Recruiting

Phase: PHASE3 Conditions: NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

NCT ID: NCT04379570

This clinical trial is looking at how an additional support program, which includes text message reminders and phone counseling, can help breast cancer patients stick to their prescribed medication...

Recruiting

Phase: PHASE3 Conditions: Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma +7 more

Main Menu

Clinical Trials in Peoria, Arizona

35 Active Trials Found in Peoria

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

RA-PRO PRAGMATIC TRIAL

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy